Published in Anticancer Res on June 24, 2003
Antibodies against the mitochondrial fraction of liver after toxic liver damage in rats. Clin Exp Immunol (1966) 2.24
Allergic alveolitis in a maltworker. Thorax (1968) 2.21
Non-secretion of ABO antigens predisposing to infection by Neisseria meningitidis and Streptococcus pneumoniae. Lancet (1986) 2.05
An outbreak of meningococcal disease in Stonehouse: planning and execution of a large-scale survey. Epidemiol Infect (1987) 1.95
Non-secretion of ABO blood group antigens as a host susceptibility factor in the spondyloarthropathies. Br Med J (Clin Res Ed) (1987) 1.91
Antibodies in human brucellosis. Br Med J (1967) 1.85
Factors influencing the immune response. I. Effects of the physical state of the antigen and of lymphoreticular cell proliferation on the response to intravenous injection of bovine serum albumin in rabbits. Clin Exp Immunol (1967) 1.85
Naturally occurring anti-tissue antibodies in rat sera. Clin Exp Immunol (1966) 1.75
Helicobacter pylori in the mouth--negative isolation from dental plaque and saliva. Eur J Gastroenterol Hepatol (1996) 1.67
Allergic alveolitis in maltworkers. A clinical, mycological, and immunological study. Q J Med (1969) 1.57
Secretor status, smoking and carriage of Neisseria meningitidis. Epidemiol Infect (1990) 1.55
Frequency and some properties of clinical isolates of methicillin-resistant Staphylococcus aureus. Am J Clin Pathol (1975) 1.54
Increased phagocytic cell activity and anaemia in Corynebacterium parvum treated mice. Br J Exp Pathol (1974) 1.53
Immune response to a soluble protein antigen in NZB mice. Nature (1968) 1.51
Implant infections: a haven for opportunistic bacteria. J Hosp Infect (2001) 1.49
Association between secretor status and respiratory viral illness. BMJ (1991) 1.47
Factors influencing the immune response. 3. The blocking effect of Corynebacterium parvum upon the induction of acquired immunological unresponsiveness to bovine serum albumin in the adult rabbit. Clin Exp Immunol (1968) 1.46
ABO blood group, secretor state, and susceptibility to recurrent urinary tract infection in women. Br Med J (Clin Res Ed) (1982) 1.35
Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. Anticancer Res (2004) 1.33
The serology of autologous immune complex nephritis in the rat. Clin Exp Immunol (1969) 1.33
Adjuvant-induced antired blood cell activity in CBA mice. Clin Exp Immunol (1971) 1.31
ABO blood group, secretor status and detection of Helicobacter pylori among patients with gastric or duodenal ulcers. Epidemiol Infect (1991) 1.30
The Stonehouse study: secretor status and carriage of Neisseria species. Epidemiol Infect (1989) 1.28
Non-secretion of ABO blood group antigens predisposing to infection by Haemophilus influenzae. Lancet (1986) 1.26
Mechanisms of macrophage activation. Clin Exp Immunol (1980) 1.25
The characteristics of binding of Corynebacterium parvum to glass-adherent mouse peritoneal exudate cells. Clin Exp Immunol (1976) 1.25
Non-specific recognition mechanisms by mononuclear phagocytes. Clin Exp Immunol (1977) 1.25
In vitro binding of Helicobacter pylori to human gastric mucin. Infect Immun (1991) 1.20
Secretor state of patients with insulin dependent or non-insulin-dependent diabetes mellitus. Br Med J (Clin Res Ed) (1987) 1.19
Toxigenic bacteria and sudden infant death syndrome (SIDS): nasopharyngeal flora during the first year of life. FEMS Immunol Med Microbiol (1999) 1.18
Activation of the classical and alternate pathways of complement by Corynebacterium parvum. Clin Exp Immunol (1975) 1.18
Factors affecting carriage of Neisseria meningitidis among Greek military recruits. Epidemiol Infect (1992) 1.18
The effect of cigarette smoke on adherence of respiratory pathogens to buccal epithelial cells. FEMS Immunol Med Microbiol (1999) 1.17
Susceptibility to infection in relation to SIDS. J Clin Pathol (1992) 1.16
The immunologicial consequences of cell death. Lancet (1967) 1.16
Antibiotic sensitivities of Neisseria meningitidis isolates from patients and carriers in Greece. Epidemiol Infect (1992) 1.15
The in vitro killing of syngeneic cells by peritoneal cells from adjuvant-stimulated mice. Cell Immunol (1975) 1.14
[Prevention, diagnosis, therapy, and follow-up of lung cancer]. Pneumologie (2010) 1.14
Non-secretion of blood group antigens and susceptibility to infection by Candida species. FEMS Microbiol Immunol (1989) 1.13
Chemotaxis of polymorphs induced by tissue antigens and normal serum in rats: a possible clearance mechanism. Clin Exp Immunol (1967) 1.07
Failure to induce tolerance to rat tissue antigens. Immunology (1967) 1.07
Antitissue antibodies and immunological tolerance to self. Arthritis Rheum (1969) 1.07
Inhibition of bacterial binding to mouse macrophages by Pseudomonas alginate. J Clin Lab Immunol (1983) 1.06
Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie (2010) 1.06
Factors influencing the immune response. II. Effects of the physical state of the antigen and of lymphoreticular cell proliferation on the response to intraperitoneal injection of bovine serum albumin in rabbits. Clin Exp Immunol (1967) 1.05
In vitro evaluation of the new oral cephalosporin cefatrizine: comparison with other cephalosporins. Antimicrob Agents Chemother (1976) 1.04
Chronic atrophic oral candidiasis among patients with diabetes mellitus--role of secretor status. Epidemiol Infect (1991) 1.03
Presence of bacterial binding 'lectin-like' receptors on phagocytes. Immunology (1981) 1.03
The role of bacterial toxins in sudden infant death syndrome (SIDS). Int J Med Microbiol (2002) 1.02
Macrophage migration inhibition induced by tissue antigen in guinea-pigs. Clin Exp Immunol (1971) 1.02
Lewis a blood group antigen of non-secretors: a receptor for candida blastospores. FEMS Microbiol Immunol (1989) 1.02
The immune response after tissue injury. Pathol Eur (1966) 1.01
The effect of prone posture on nasal temperature in children in relation to induction of staphylococcal toxins implicated in sudden infant death syndrome. FEMS Immunol Med Microbiol (1999) 1.01
Blood group, secretor status and oral carriage of yeasts among patients with diabetes mellitus. Diabetes Res (1989) 1.00
The in vitro activity of peritoneal exudate cells from New Zealand black mice (NZB/B1) in the presence of I-125-BSA (bovine serum albumin). Clin Exp Immunol (1972) 1.00
Development of anti-tissue antibodies in rats. Clin Exp Immunol (1969) 1.00
Heat labile antibody in rat serum. Clin Exp Immunol (1968) 0.99
Binding of bacteria to HEp-2 cells infected with influenza A virus. FEMS Immunol Med Microbiol (1999) 0.98
Isolation of a cell surface component of Helicobacter pylori that binds H type 2, Lewis(a), and Lewis(b) antigens. Gastroenterology (1997) 0.97
Increased inflammatory responses of persons of blood group O to Helicobacter pylori. J Infect Dis (2000) 0.97
Antimicrobial substances and effects on sessile bacteria. Zentralbl Bakteriol (1999) 0.97
The role of infectious agents in sudden infant death syndrome. FEMS Immunol Med Microbiol (1994) 0.97
The role of cell wall carbohydrates in binding of microorganisms to mouse peritoneal exudate macrophages. Acta Pathol Microbiol Scand B (1978) 0.97
The effect of Pseudomonas alginate on rat alveolar macrophage phagocytosis and bacterial opsonization. Clin Exp Immunol (1985) 0.96
Detection of pyrogenic toxins of Staphylococcus aureus in sudden infant death syndrome. FEMS Immunol Med Microbiol (1999) 0.96
Interaction of bacteria with the immune system. J Clin Lab Immunol (1983) 0.96
Binding of type-III group-B streptococci to buccal epithelial cells. J Med Microbiol (1982) 0.96
Alteration of pyocin-sensitivity pattern of Neisseria gonorrhoeae is associated with induced resistance to killing by human serum. J Gen Microbiol (1984) 0.94
Serogroups, serotypes and subtypes of Neisseria meningitidis isolated from patients and carriers in Greece. J Med Microbiol (1993) 0.94
Binding of microorganisms to the macrophage plasma membrane; effects of enzymes and periodate. Br J Exp Pathol (1978) 0.94
Increased prevalence of non-secretors in patients with Graves' disease: evidence for an infective aetiology? Br Med J (Clin Res Ed) (1988) 0.94
Phenotypic and genotypic approaches to characterization of isolates of Neisseria meningitidis from patients and their close family contacts. J Clin Microbiol (2001) 0.94
Influence of postoperative complementary treatment with lectin-standardized mistletoe extract on breast cancer patients. A controlled epidemiological multicentric retrolective cohort study. Anticancer Res (2004) 0.93
Typing of non-serogroupable Neisseria meningitidis by means of sensitivity to R-type pyocines of Pseudomonas aeruginosa. J Infect (1981) 0.92
Immunostimulation by propionibacteria--effects on immune status and antineoplastic treatment. Anticancer Res (1996) 0.92
Infection with respiratory syncytial virus enhances expression of native receptors for non-pilate Neisseria meningitidis on HEp-2 cells. FEMS Immunol Med Microbiol (1999) 0.92
Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H). Anticancer Res (1999) 0.91
Effect of respiratory syncytial virus infection on binding of Neisseria meningitidis and Haemophilus influenzae type b to a human epithelial cell line (HEp-2). Epidemiol Infect (1993) 0.91